BMC Cancer (Sep 2018)

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report

  • Federica Isidori,
  • Deborah Malvi,
  • Silvia Fittipaldi,
  • Claudio Forcato,
  • Isotta Bozzarelli,
  • Claudia Sala,
  • Giovanni Raulli,
  • Antonia D’Errico,
  • Michelangelo Fiorentino,
  • Marco Seri,
  • Kausilia K. Krishnadath,
  • Elena Bonora,
  • Sandro Mattioli,
  • EAC-BAGH group

DOI
https://doi.org/10.1186/s12885-018-4789-4
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background We report on a female patient who underwent primary radical resection for a stage 2B Her-2-positive Barrett’s-type esophageal adenocarcinoma (EAC). Despite Her-2 targeted therapy, her disease recurred and required repeated metastectomies. Case presentation Digital cell sorting and targeted sequencing of cancer sub-clones from EAC and metastases revealed a completely mutated TP53, whereas the sorted stromal cells were wild-type. Her-2 amplification was significantly lower in the metastases when the patient became therapy-resistant. Conclusions The mechanism of therapy resistance illustrated by this case could only be detected through accurate analysis of tumor sub-populations. Investigating tumor sub-populations of recurrent disease is important for adjusting therapy in recurrent EAC.

Keywords